Home › Therapeutic areas › Immunology › Chronic Urticaria

Chronic Urticaria (8 companies)

Companies with an active program in Chronic Urticaria.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
RCUS Arcus Biosciences DermatologyImmunology+1 1 Phase 3 $2.36B 8
CLDX Celldex Therapeutics DermatologyImmunology+1 4 Phase 3 $2.20B 6
CUE Cue Biopharma ImmunologyOncology 1 Phase 2 $23.7M 6
ENTA Enanta Pharmaceuticals DermatologyImmunology+2 1 Approved $253M 8
EVMN Evommune DermatologyImmunology+1 1 Phase 2 $290M 6
NRIX Nurix Therapeutics ImmunologyNeurology+1 1 Phase 3 $1.56B 13
PCSA Processa Pharmaceuticals GI/HepatologyImmunology+2 Rare 1 Phase 2 $4.8M 7
SEPN Septerna ImmunologyMetabolic+1 Rare 2 Phase 1 $1.90B 5